Lifestyle, health and disease prevention: The underlying mechanisms

European Journal of Cancer Prevention

Volumn 11, Issue SUPPL. 2, 2002, Pages

  Weisburger, J H ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Antioxidants; Cancer; Economics; Fats; Fiber; Fruits; Heart disease; Heterocyclic amines; Minerals; Optimal nutrition; Prevention; Promotion; Reactive oxygen species (ROS); Salt; Tea; Vegetables; Vitamins

Indexed keywords

ANTIOXIDANT; HETEROCYCLIC AMINE; MINERAL; REACTIVE OXYGEN METABOLITE; VITAMIN;

BACTERIAL FLORA; CANCER PREVENTION; CANCER RISK; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; EXERCISE; FAT INTAKE; FOOD INTAKE; GENOTOXICITY; HEALTH BEHAVIOR; HEALTH PROMOTION; HEART DISEASE; HUMAN; LIFESTYLE; NUTRITION; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STROKE; VEGETABLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; DIET; FEMALE; HEALTH EDUCATION; MALE; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ANTIOXIDANTS; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DIET; EXERCISE; FEMALE; HEALTH EDUCATION; HUMANS; LIFE STYLE; MALE; NEOPLASMS; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0036702029     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Beaglehole R (1999). International trends in coronary heart disease mortality and incidence rates. J Cardiovas Risk 6: 63-8.
2. Chen W, Weisburger JH, Fiala ES, et al. (1996). Gastric carcinogenesis: 2-chloro-4-methylthiobutanoic acid, a novel mutagen in salted, pickled Sanma Hiraki fish, or similarly treated methionine. Chem Res Toxicol 9: 58-66.
3. Conney AH, Lu Y, Lou Y, Xie J, Huang M (1999). Inhibitory effect of green and black tea on tumor growth. Proc Soc Exp Biol Med 220: 229-33.
4. Degen GH, Vogel C, Abel Josef (2002). Prostaglandin synthases. In Enzyme Systems that Metabolise Drugs and Other Xenobiotics (ed. Ioannides C); John Wiley, Chichester, pp. 189-229.
5. Eling TE, Thompson DC, Foureman GL, et al. (1990). Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 30: 1-45.
6. Embola CW, Weisburger JH, Weisburger MC (2001). Detoxification of 2-amino-3-methylmidazo [4,5-f]quinolines (IQ) via the urinary excretion of N-OH-IQ-glucuronide in F344 rats is enhanced by green tea. Carcinogenesis 22: 1095-8.
7. Fahey JW, Talalay P (1999). Antioxidant functions of sulforaphane: A potent inducer of Phase II detoxification enzymes. Ed Chem Toxicol 37: 973-9.
8. Felton JS, Gentile JM (1997). Mutagenic/carcinogenic N-substituted aryl compounds. Mutat Res 376: 1-276.
9. Fraser GE (1999). Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr 70(3 Suppl): 532S-8.
10. Fujiki H, Suganuma M, Okabe S, et al. (2000). A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea - a review. Cancer Detection Prev 24: 91-9.
11. Greenlee RT, Hill-Harmon MB, Murray T, et al. (2001). Cancer statistics, 2001. CA Cancer J Clin 51: 15-36.
12. Greenwald P, Clifford CK, Milner JA (2001). Diet and cancer prevention. Eur J Cancer 37: 948-65.
13. Grundy SM, Cleeman JI, Rifkind BM, et al. (1999). Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med 159: 1670-8.
14. Hara Y (2001). Green Tea. Marcel Dekker, New York, p. 252.
15. Howson CP, Hiyama T, Wynder EL (1986). Decline of gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 8: 1-27.
16. Hwang H, Dwyer J, Russell RM (1994). Diet, Helicobacter pylori infection, food preservation and gastric cancer risk: Are there new roles for preventative factors? Nutr Rev 52: 75-83.
17. Ito N (1999). The 7th International Conference on Carcinogenic and Mutagenic N-Substituted Aryl Compounds. Cancer Lett 143: 99-266.
18. Jägerstad M, Skog K, Grivas S, et al. (1991). Formation of heterocyclic amines using model systems. Mutat Res 259: 219-33.
19. Joossens J, Kesteloot H (1988). Salt and stomach cancer. In Gastric Carcinogenesis (eds Reed PI, Hill MJ); Excerpta Medica, Amsterdam, pp. 26-105.
20. Kuroda Y, Hara Y (1999). Antimutagenic and anticarcinogenic activity of tea polyphenols. Mütat Res 436: 69-97.
21. La Vecchia C, Tavani A (1998). Fruit and vegetables, and human cancer. Eur J Cancer Prev 7: 3-8.
22. Lin JM, Liang YC, Lin-Shiau (1999). Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol 58: 911-5.
23. Lipkin M, Reddy B, Newmark H, Lamprecht SA (1999). Dietary factors in human colorectal cancer. Annu Rev Nutr 19: 545-86.
24. Loeb LA (2001). A mutator phenotype in cancer. Cancer Res 61: 3230-9.
25. Mukhtar H, Ahmad N (2000). Tea polyphenols: Prevention of cancer and optimizing health. Am J Clin Nutr 71(Suppl 6): 1703-4.
26. Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancer in 1990. Int J Cancer 80: 827-41.
27. Rao CV, Newmark HL, Reddy BS (1998). Chemopreventive effect of squalene on colon cancer. Carcinogenesis 19: 287-90.
28. Reddy BS, Hirose Y, Cohen LA, et al. (2000). Preventive potential of wheat bran fractions against experimental colon carcinogenesis: Implications for human colon cancer prevention. Cancer Res 60: 4792-7.
29. Rose DP (1993). Diet, hormones, and cancer. Annu Rev Pub Health 14: 1-17.
30. Sasco AJ, Kleihues P (1999). Why can't we convince the young not to smoke? Eur J Cancer 35: 1933-40.
31. Segall JJ (1994). Dietary lactose as a possible risk factor for ischaemic heart disease: Review of epidemiology. Int J Cardiol 46: 197-207; ibid.
32. Segall JJ (1994). Dietary lactose as a possible risk factor for ischaemic heart disease: Review of epidemiology. Int J Cardiol 46: 197-207; ibid.
33. Stumpf K, Pietinen P, Puska P, Aldercreutz H (2000). Changes in serum enterolactone, genisten, and daidzein in a dietary intervention study in Finland. Cancer Epidemiol Biomarkers Prev 9: 1369-72.
34. Sugimura T (1996). An overview of cancer prevention. Eur J Cancer Prev 5(Suppl 2): 1-8.
35. Sugimura T (2000). Nutrition and dietary carcinogens. Carcinogenesis 21: 387-95.
36. Trichopoulou A, Vasilopoulou E, Lagiou A (1999). Mediterranean diet and coronary heart disease: Are antioxidants critical? Nutr Rev 57: 253-5.
37. Trosko JE (2001). Commentary: Is the concept of 'tumor promotion' a useful paradigm? Mol Carcinog 30: 131-7.
38. Wattenberg LW (1997). An overview of chemoprevention: Current status and future prospects. Proc Soc Exp Biol Med 216: 133-41.
39. Weisburger JH (1997). Dietary fat and risk of chronic disease: Mechanistic insights from experimental studies. J Am Dietetic Assoc 97(Suppl): S16-S23.
40. Weisburger JH (1999). Tea and health: The underlying mechanisms. Proc Soc Exp Biol Med 220: 271-5.
41. Weisburger JH (2000). Eat to live, not live to eat. Nutrition 16: 767-73.
42. Weisburger JH, Williams GM (2000). The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. Toxicol Sci 57: 4-5.
43. Williams GM, Williams CL, Weisburger JH (1999). Diet and cancer prevention: The Fiber first Diet. Toxicol Sci 52(Suppl): 72-86.
44. Yang CS, Landau JM (2000). Effects of tea consumption on nutrition and health. J Nutr 130: 2409-12.